# Spero Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/spero-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:53:12.75153+00:00 | | Last reviewed | 2026-10-16T13:53:12.75153+00:00 | ## Identity - Legal name: Spero Therapeutics, Inc. - Display name: Spero Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T04:39:31.386941+00:00 | | Completeness | 0.364 | | Record Quality | 0.832 | | Directors | 9 | | Committees | 6 | | Governance events | 16 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | NOT_REVIEWED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Ankit Mahadevia, M.D.: Director. Status: current. Independent: false. Since: 2013-01-01. claim_id=alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:7 - Cynthia Smith: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:8 - Esther Rajavelu: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:9 - Frank E. Thomas: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:10 - John C. Pottage, Jr., M.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:11 - Kathleen Tregoning: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:12 - Milind Deshpande, Ph.D.: Director. Status: current. Independent: true. Since: 2014-01-01. claim_id=alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:13 - Patrick Vink, M.D.: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:14 - Sharon L. Jackson: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:15 ## Committees - Audit (audit). Chair: Frank E. Thomas. Members: Frank E. Thomas (chair, current); Sharon L. Jackson (member, current). committee_id=alpha:committee:spero-therapeutics-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Frank E. Thomas (member, current). committee_id=alpha:committee:spero-therapeutics-inc:audit-chair - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Sharon L. Jackson (member, current). committee_id=alpha:committee:spero-therapeutics-inc:audit-nominating-and-governance - Compensation (compensation). Chair: Cynthia Smith. Members: Cynthia Smith (chair, current); Kathleen Tregoning (member, current). committee_id=alpha:committee:spero-therapeutics-inc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Cynthia Smith (member, current). committee_id=alpha:committee:spero-therapeutics-inc:compensation-chair - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Sharon L. Jackson (member, current). committee_id=alpha:committee:spero-therapeutics-inc:nominating-and-governance ## Governance events - DIRECTOR_APPOINTED: Esther Rajavelu seat on Spero Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:16rjw2914r0s9 - DIRECTOR_APPOINTED: Kathleen Tregoning seat on Spero Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:ilccandfe15j - COMMITTEE_MEMBER_ADDED: Kathleen Tregoning member of Compensation, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:18x2itovnyud - DIRECTOR_APPOINTED: Sharon L. Jackson seat on Spero Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:1x38837np7vx - COMMITTEE_CREATED: Audit; Nominating and Governance committee of Spero Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:7ryg11djdw8x - COMMITTEE_MEMBER_ADDED: Sharon L. Jackson member of Audit; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:1mi7tf11q5unh7 - DIRECTOR_APPOINTED: Cynthia Smith seat on Spero Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:1ywlri11vyf2v7 - COMMITTEE_CREATED: Compensation · Chair committee of Spero Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:gaan8p78a6b - COMMITTEE_MEMBER_ADDED: Cynthia Smith member of Compensation · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:co3axq17b5ti2 - DIRECTOR_APPOINTED: John C. Pottage, Jr., M.D. seat on Spero Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:1rtews21br210u - DIRECTOR_APPOINTED: Frank E. Thomas seat on Spero Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:5vx75e1kvrfws - COMMITTEE_CREATED: Audit · Chair committee of Spero Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:1r6bprm1t0y0k4 - COMMITTEE_MEMBER_ADDED: Frank E. Thomas member of Audit · Chair, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:18rglmkelq94s - DIRECTOR_APPOINTED: Patrick Vink, M.D. seat on Spero Therapeutics, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:u5lm8s1wsqmnu - DIRECTOR_APPOINTED: Milind Deshpande, Ph.D. seat on Spero Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:8usm8wh0ffjs - DIRECTOR_APPOINTED: Ankit Mahadevia, M.D. seat on Spero Therapeutics, Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T13:53:12.75153+00:00. event_id=alpha:event:transition:1y5tug430tjfy ## Scoped resources - `alpha://company/spero-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record - `alpha://company/spero-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=identity - `alpha://company/spero-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/spero-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=board - `alpha://company/spero-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=committees - `alpha://company/spero-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=leadership - `alpha://company/spero-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=ownership - `alpha://company/spero-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=financials - `alpha://company/spero-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/spero-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=compensation - `alpha://company/spero-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=governance - `alpha://company/spero-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/spero-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=audit - `alpha://company/spero-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=legal - `alpha://company/spero-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=risk - `alpha://company/spero-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=cyber - `alpha://company/spero-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/spero-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=agents - `alpha://company/spero-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/spero-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=events - `alpha://company/spero-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=relationships - `alpha://company/spero-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=assessments - `alpha://company/spero-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:frank-e-thomas","name":"Frank E. Thomas"},"source_id":"board_seats"}` - Claim alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:scott-jackson","name":"Sharon L. Jackson"},"source_id":"board_seats"}` - Claim alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:cynthia-smith","name":"Cynthia Smith"},"source_id":"board_seats"}` - Claim alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kathleen-tregoning","name":"Kathleen Tregoning"},"source_id":"board_seats"}` - Claim alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:scott-jackson","name":"Sharon L. Jackson"},"source_id":"board_seats"}` ## Leadership - Ankit Mahadevia, M.D.: Director. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:7. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c. - Cynthia Smith: Director, Compensation · Chair. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:8. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c. - Esther Rajavelu: Director. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c. - Frank E. Thomas: Director, Audit · Chair. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c. - John C. Pottage, Jr., M.D.: Director. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:11. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c. - Kathleen Tregoning: Director, Compensation. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c. - Milind Deshpande, Ph.D.: Director. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:13. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c. - Patrick Vink, M.D.: Director. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:14. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c. - Sharon L. Jackson: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:15. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Frank E. Thomas; Members Frank E. Thomas (Chair); Sharon L. Jackson. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71. - Compensation: Chair Cynthia Smith; Members Cynthia Smith (Chair); Kathleen Tregoning. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71. - Nominating and Governance: Chair not stated; Members Sharon L. Jackson. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Spero Therapeutics, Inc.. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0fae3f4ca4bd2b87e39da28de4704d4bd675ba03d9b7f5ac42a5f71cadc25156. ## Entity Status - Public listing published. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0fae3f4ca4bd2b87e39da28de4704d4bd675ba03d9b7f5ac42a5f71cadc25156. ## Published Fact - US. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0fae3f4ca4bd2b87e39da28de4704d4bd675ba03d9b7f5ac42a5f71cadc25156. - Healthcare. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0fae3f4ca4bd2b87e39da28de4704d4bd675ba03d9b7f5ac42a5f71cadc25156. - Biotechnology. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0fae3f4ca4bd2b87e39da28de4704d4bd675ba03d9b7f5ac42a5f71cadc25156. ## Committee Appointment - Frank E. Thomas: chair, Audit. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71. - Sharon L. Jackson: member, Audit. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71. - Cynthia Smith: chair, Compensation. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71. - Kathleen Tregoning: member, Compensation. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71. - Sharon L. Jackson: member, Nominating and Governance. Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71. ## Security Listing - SPRO (NASDAQ). Claim: alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0fae3f4ca4bd2b87e39da28de4704d4bd675ba03d9b7f5ac42a5f71cadc25156. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:0fae3f4ca4bd2b87e39da28de4704d4bd675ba03d9b7f5ac42a5f71cadc25156: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/spero-therapeutics-inc). - alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c: [Spero Therapeutics, Inc. DEF 14A 2025-04-28](https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm). - alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71: [Audit](https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/spero-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/spero-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/spero-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T04:39:31.194047+00:00; recorded 2026-10-17T04:39:31.194047+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.